Skip to content

The effects of different induction of oocyte maturation on the outcome of PCOS patients during PPOS

The study of progestin-primed ovarian stimulation

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800017907
Enrollment
Unknown
Registered
2018-08-21
Start date
2013-01-01
Completion date
Unknown
Last updated
2018-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

infertility

Interventions

single trigger group:GnRH-a 0.1mg
Double Trigger group:GnRH-a 0.1mg+HCG
single trigger grou:GnRH-a 0.2mg
Double Trigger group:GnRH-a 0.2mg+HCG

Sponsors

Shanghai Ninth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. Patients with PCOS; The major criteria for diagnosis of PCOS were oligo- and/or anovulation, clinical or biochemical signs of hyperandrogenism and polycystic ovaries; these criteria are in accordance with the revised 2003 Rotterdam criteria for PCOS; 2. age 18 to 40 years, no endometriotic cyst present, as assessed by transvaginal ultrasound examination.

Exclusion criteria

Exclusion criteria: Clinically significant systemic disease such as renal failure; endometriosis grade 3 or higher; documented ovarian failure including basal FSH above 10 IU/L; received hormonal treatments in the previous 3 months; any contraindications to ovarian stimulation treatment.

Design outcomes

Primary

MeasureTime frame
the rate of oocyte-obtained;number of available embryo;clinical pregnancy rate;embryo implantation rate;the level of LH;

Countries

China

Contacts

Public ContactYanping Kuang

Shanghai Ninth People's Hospital

kuangyanp@126.com+86 021-53078108

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026